PSA screening and prostate cancer risk reduction - ScienceDirect

Urologic Oncology: Seminars and Original Investigations

Volume 30, Issue 6, November–December 2012, Pages 936-937

Urologic Oncology: Seminars and Original Investigations

https://doi.org/10.1016/j.urolonc.2012.09.009 Get rights and content

References (0)

Cited by (9)

The levels of circulating long non-coding RNA GAS5 in prostate carcinoma patients: a single-center study
2023, Vojnosanitetski Pregled
Analysis of circulating tumor cells in patients with non-metastatic high-risk prostate cancer before and after radiotherapy using three different enumeration assays
2019, Cancers
Eukaryotic Translation Initiation Factor 4 Gamma 1 (eIF4G1) is upregulated during Prostate cancer progression and modulates cell growth and metastasis
2018, Scientific Reports
The profile feasibility study: Targeted screening of men with a family history of prostate cancer
2016, Oncologist
Next generation biomarkers in prostate cancer
2016, Frontiers in Bioscience - Landmark
Histopathological characteristics of microfocal prostate cancer detected during systematic prostate biopsy
2015, BJU International

View all citing articles on Scopus

Copyright © 2012 Elsevier Inc. All rights reserved.